Pivotal phase III trial of darinaparsin + CHOP in patients wih peripheral T-cell lymphoma
Phase of Trial: Phase III
Latest Information Update: 17 May 2011
At a glance
- Drugs Cyclophosphamide; Darinaparsin; Doxorubicin; Prednisone; Vincristine
- Indications Peripheral T-cell lymphoma
- Focus Registrational; Therapeutic Use
- Sponsors ZIOPHARM Oncology
- 17 May 2011 Planned initiation date changed to 1 Dec 2011.
- 21 Jan 2011 Ziopharm received positive opinion for orphan drug desigination for darinaparsin for EMA, according to a Ziopharm media release
- 29 Jan 2010 New trial record.